retatrutide gcg Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

The medication costs $199 per month (28-day supply) for the first two months of the two lowest doses, then $399 or $499 per month (28-day supply, price depends on dose) when filled through NovoCare Pharmacy

PlexusDx Precision Peptide Genetic Test ($99 add-on after month one) reveals how your GLP1R rs6923761, GIPR rs1800437, and other key variants influence your semaglutide response

Some excipients can affect GI tolerability

Our starter program is only available for new patients beginning on the lowest available dosage, requires payment upfront and in full, and includes all provider consultations, support, and medication costs if prescribed

Detailed Side-Effect Tracking and Journaling This tool features a robust side-effect tracker and journal, enabling users to log symptoms like nausea, constipation, and fatigue, along with their timing and severity

The most common side effects of semaglutide are gastrointestinal and may include: Nausea Vomiting Diarrhea Stomach pain If you are experiencing these symptoms, reach out to our Relive Houston center for a consultation